Again this describes the research schedule, not a treatment plan for a person
Wang G-J, Tomasi D, Backus W, Wang R, Telang F, Geliebter A, et al
Kamphorst, J
The largest trial involving DSIP to date, which included a total of 107 volunteers, reported that the peptide was generally well-tolerated with mostly minor side effects, which included [8]: Low blood pressure Increased sweating Headache Nausea Vertigo Considering that the drop in blood pressure was reported as moderate to severe in some patients, researchers should consider hypotension as a potentially exclusionary criterion for DSIP research
Mounjaro (tirzepatide) is a prescription medicine used for type 2 diabetes mellitus and, in certain patients, weight management
Psoriasis and Eczema